Companies
Qualcomm Unveils Next-Gen Technologies at MWC Barcelona to Propel Generative AI and Connectivity
At the Mobile World Congress in Barcelona, Qualcomm Technologies, Inc. (QCOM) made waves with its groundbreaking advancements in on-device AI,...
Beyond Boundaries: BYD’s Electric Evolution
In a groundbreaking move, Chinese automaker BYD unveiled its latest marvel over the weekend—the U9 supercar, marking its foray into...
Earnings Ascend: Berkshire’s Skyward Soar
As Berkshire Hathaway shares surged on the back of robust earnings, Warren Buffett’s empire solidified its reign in the financial...
Cable One Falls Short in Q4 and Full Year 2023Earnings
Cable One, Inc. (CABO) released its financial and operational results for the quarter and fiscal year ending December 31, 2023,...
Intuit Surpasses Earnings Estimates but Falls Short on Q3 Guidance
Financial software giant Intuit (INTU) exceeded Wall Street's earnings projections for its fiscal second quarter while reporting sales in line...
Carvana Achieves Record Sales and Profits in 2023, Sets Ambitious Goals for 2024
Carvana Co. (CVNA), a prominent e-commerce platform specializing in used car sales, announced its financial results for the fourth quarter...
Block Inc Surpasses Revenue Expectations in Q4 Financial Report
Block Inc (SQ) revealed its fourth-quarter financial performance post-market close on Thursday, marking notable highlights for investors. The company reported...
Weathering the Storm: Mativ Holdings’ Strategic Voyage
In the wake of challenging market conditions, Mativ Holdings, Inc. (MATV) finds itself on a tumultuous yet hopeful journey. Despite...
Ocular Therapeutix Announces Private Placement to Bolster Clinical Development Initiatives
Ocular Therapeutix, Inc. (OCUL), a pioneering biopharmaceutical company dedicated to advancing vision-related therapies, has disclosed its strategic move to enhance...
Monopar’s MNPR-101 Radiopharma Program Shows Promise in Targeting Advanced Cancers
Monopar Therapeutics (MNPR) has unveiled promising preclinical data for its MNPR-101 radiopharmaceutical program, marking a significant stride in the fight...
